![shutterstock_150559310](https://www.nationalelfservice.net/cms/wp-content/uploads/2014/06/shutterstock_150559310-150x150.jpg)
Alex Langford summarises a relatively large and pragmatic study, which provides firm evidence that the newer antipsychotic, Paliperidone, is no better at preventing relapse or controlling psychotic symptoms than its decades-old comparator, Haloperidol.
[read the full story...]